Regulatory Record: Yangzhou Hongshengding Chemical Co., Ltd.

FDA action counts

Risk pattern analysis

Argus HQ analysis — not an FDA finding

This section is Argus HQ analysis, not an FDA finding. Yangzhou Hongshengding Chemical Co., Ltd. has 1 FDA event on file. A pattern across multiple FDA touchpoints does not by itself establish that any specific product currently poses a risk; it reflects only the frequency of FDA engagement with this company as recorded in Argus HQ's database. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ does not independently verify FDA's underlying findings; this page summarizes what FDA has published and links back to the original FDA source for each event. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures.

Enforcement history

On 2026-06-15, Argus HQ recorded an FDA Warning Letter for Yangzhou Hongshengding Chemical Co., Ltd., rated "high" severity in Argus HQ's classification: Yangzhou Hongshengding Chemical Co., Ltd. — Refusal to Provide Access to and Copying of Records (2026-06-15). Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed.

Frequently asked questions

Has Yangzhou Hongshengding Chemical Co., Ltd. received FDA warning letters?

Yes, 1 warning letter on file. See the full history below for each one.

Is this FDA enforcement data for Yangzhou Hongshengding Chemical Co., Ltd. official?

Every record links directly to its primary FDA.gov source. Argus HQ aggregates and structures public FDA data; the verbatim FDA record is always the source of truth.

How many FDA actions has Yangzhou Hongshengding Chemical Co., Ltd. had?

Argus HQ has recorded 1 FDA events for Yangzhou Hongshengding Chemical Co., Ltd.: 1 warning letters, 0 recalls, 0 approvals, and 0 Form 483 inspection observations. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures.

What is the most recent FDA action against Yangzhou Hongshengding Chemical Co., Ltd.?

The most recent FDA event Argus HQ has on file for Yangzhou Hongshengding Chemical Co., Ltd. is dated 2026-06-15, with a severity rating of "high" in Argus HQ's classification. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures.

Related enforcement actions

• Yangzhou Hongshengding Chemical Co., Ltd. — Refusal to Provide Access to and Copying of Records (2026-06-15) →

Compare with

• Yangzhou Hongshengding Chemical Co., Ltd. vs Philips North America
• Yangzhou Hongshengding Chemical Co., Ltd. vs Medline Industries, LP
• Yangzhou Hongshengding Chemical Co., Ltd. vs Boston Scientific Corporation
• Yangzhou Hongshengding Chemical Co., Ltd. vs Baxter Healthcare Corporation
• Yangzhou Hongshengding Chemical Co., Ltd. vs PHILIPS MEDICAL SYSTEMS NEDERLAND B.V.